A new formulation of collagenase ointment (Iruxol® mono) in the treatment of ulcers of the lower extremities. A randomised, placebo-controlled, double-blind study

Clinical Drug Investigation

Volumn 15, Issue 5, 1998, Pages 381-387

  Palmieri, Beniamino ^a   Magri, Marco ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Knoll Farmaceutica SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; IRUXOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPITHELIZATION; ERYTHEMA; FEMALE; HUMAN; INFLAMMATION; LEG; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSATION; TOPICAL DRUG ADMINISTRATION; ULCER; WOUND HEALING;

EID: 0031801061     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199815050-00002     Document Type: Article

References (17)

1. Hatz RA, Niedner R, Vansheidt W, et al. editors. Wound healing and wound management. Berlin: Springer-Verlag, 1994
2. Varma AO, Bugatch E, German FM. Debridement of dermal ulcers with collagenase. Surg Gynecol Obstet 1973; 136: 281-2
3. Herman IM. Stimulation of human keratinocyte migration and proliferation in vitro: insights into the cellular responses to injury and wound healing. Wound Compend Clin Res Pract 1996; 8: 33-41
4. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978; 75: 871-5
5. Radice M, Cardarelli L, Cortivo R, et al. Chemotactic properties of human collagen breakdown products in wound healing. In: Abatangelo G, Donati L, Vansheidt W, editors. Proteolysis in wound repair. Berlin: Springer-Verlag, 1996
6. Vanscheidt W. Management of wound healing. Insert in Der Hautarzt 1992: 43
7. Helaly P, Vogt E, Scheider G. Wound healing impairment and topical enzymatic therapy: a multicentre double-blind study. Schweiz Rundsch Med Prax 1988; 77: 1428-34
8. Hatz RA, Nieder R, Vanscheidt W, et al. Wound healing and wound management. Berlin: Springer Verlag 1994, 57-64
9. Wilkowska A, Czubek M, Szarmach H. Ocena skutecznosci preparatu Iruxol® mono w leczeniu owrzodzen. Przegl Dermatol 1995; 82: 555-62
10. Blum G. Therapeutische Erfahrungen mit IRUXOL® bei ulcera cruris decubitus und Verbrennungen. Schweiz Rundsch Med Prax 1973; 62: 820-6
11. Helaly P, Villiger KJ, Vogt E. Enzymatic debridement of surgical necrotic wounds with a collagenase-containing preparation (Iruxol®/Santyl®). Schweiz Rundseh Med Prax 1980; 69: 703-11
12. Mazurek I. Bericht über die klinische Prüfung von Iruxol-salbe. Med Welt 1971; 22: 150-3
13. Paul E. Wound healing with Iruxol. Results of a multicentre study. Fortschr Med 1990; 108: 679-81
14. Altman MI, Goldstein L, Horowitz S. Collagenase. An adjunct to healing trophic ulcerations in the diabetic patient. J Am Podiatr Assoc 1978; 68: 11-5
15. Harding KG, Bale S, Llewellyn M, et al. A pilot study of clostridium collagenase ointment (Collagenase ABC) in the debridement of dermal ulcers. Clin Drug Invest 1996; 11: 139-44
16. Lee LK, Ambrus JL. Collagenase therapy for decubitus ulcers. Geriatrics 1975; 30: 91-8
17. Rao DB, Sane PG, Georgiev EL. Collagenase in the treatment of dermal and decubitus ulcers. J Am Geriatr Soc 1975; 23: 22-30